Cakmak, M. E. Et Al. 2020. Mortality due to COVID-19 in a Patient with Severe Asthma Receiving Omalizumab Treatment: A Case Report. ASTIM ALLERJI IMMUNOLOJI , vol.18 , 27-29.

Cakmak, M. E., KAYA, S. B., CAN BOSTAN, Ö., TUNCAY, G., DAMADOĞLU, E., KARAKAYA, G., ... KALYONCU, A. F.(2020). Mortality due to COVID-19 in a Patient with Severe Asthma Receiving Omalizumab Treatment: A Case Report. ASTIM ALLERJI IMMUNOLOJI , vol.18, 27-29.

Cakmak, Mehmet Et Al. "Mortality due to COVID-19 in a Patient with Severe Asthma Receiving Omalizumab Treatment: A Case Report," ASTIM ALLERJI IMMUNOLOJI , vol.18, 27-29, 2020

Cakmak, Mehmet E. Et Al. "Mortality due to COVID-19 in a Patient with Severe Asthma Receiving Omalizumab Treatment: A Case Report." ASTIM ALLERJI IMMUNOLOJI , vol.18, pp.27-29, 2020

Cakmak, M. E. Et Al. (2020) . "Mortality due to COVID-19 in a Patient with Severe Asthma Receiving Omalizumab Treatment: A Case Report." ASTIM ALLERJI IMMUNOLOJI , vol.18, pp.27-29.

@article{article, author={Mehmet Erdem Cakmak Et Al. }, title={Mortality due to COVID-19 in a Patient with Severe Asthma Receiving Omalizumab Treatment: A Case Report}, journal={ASTIM ALLERJI IMMUNOLOJI}, year=2020, pages={27-29} }